Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery
NCT ID: NCT02038062
Last Updated: 2016-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2010-05-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sevoflurane
Sevoflurane Preconditioning
Sevoflurane preconditioning
Preconditioning by transient application of sevoflurane
No Sevoflurane
No Sevoflurane Preconditioning
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sevoflurane preconditioning
Preconditioning by transient application of sevoflurane
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Schleswig-Holstein
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Axel Fudickar
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Axel Fudickar, Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Schleswig-Holstein
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Schleswig-Holstein, Campus Kiel
Kiel, Schleswig-Holstein, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fudickar A, Kunath S, Voss D, Siggelkow M, Cavus E, Steinfath M, Bein B. Effect of ischemic and pharmacological preconditioning of lower limb muscle tissue on tissue oxygenation measured by near-infrared spectroscopy--a pilot study. BMC Anesthesiol. 2014 Jul 15;14:54. doi: 10.1186/1471-2253-14-54. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Fudickar7
Identifier Type: -
Identifier Source: org_study_id